UNSPSC 42222200: Needleless intravenous injection and withdrawal systems

In this classification, this class includes, systems, components, accessories, and supplies, utilized in needleless intravenous injection and withdrawal based medical procedures.

UNSPSC 42222200 Needleless intravenous injection and withdrawal systems is a Class code covering IV access devices, infusion equipment, and related medical supplies that state and local governments procure for healthcare facilities, emergency medical services, and institutional care settings. Recent solicitations show state and local buyers acquiring specific branded needleless IV systems (such as Vidacare EZ-IO intraosseous infusion devices), IV stabilization devices, and ancillary infusion equipment from manufacturers including Becton Dickinson, Cardinal Health, and C.R. Bard. Issuing bodies include state health and human services agencies, county emergency medical services, university health science centers, and specialized state-supported living facilities. The work spans procurement of both discrete medical devices and consumable supplies, often structured as blanket purchase agreements or service contracts with firm fixed pricing and volumes that vary based on facility needs.

Activity under the code concentrates in Texas, where the Texas Health and Human Services Commission sought medical supplies including IV stabilization devices for the Abilene State Supported Living Center (IFB HHS0017603, due July 30, 2026) and the University of Texas Health Science Center at San Antonio solicited management and operation of an outpatient infusion center (RFP 74526P16, due August 7, 2026). Marion County, Florida procured Vidacare EZ-IO intraosseous infusion systems for emergency medical services operations (procurement 09SS-103, due May 11, 2026). A Sourcewell cooperative purchasing vehicle (RFP 061626, due June 16, 2026) advertised law enforcement equipment to multiple Washington state counties and other jurisdictions, though this opportunity appears unrelated to the needleless IV code's scope. Texas and Florida show the clearest recent activity under the code's nominal scope, with opportunities typically offering 15- to 30-day response windows and structured around firm pricing, performance delivery capability, and equipment specifications tied to recognized manufacturer product lines.